Effect of intraperitoneal cannabidiol (CBD) injection on intestine microbiome profile in a mouse model

腹腔注射大麻二酚 (CBD) 对小鼠模型肠道微生物群谱的影响

阅读:3

Abstract

Cannabidiol (CBD) as an active ingredient is widely used in cosmetics, food, medical products, and dietary supplements. Recent studies suggest that CBD consumption may influence the gut microbiome, impacting overall health. The mechanism of CBD action on the intestinal microbiome may be linked to the endocannabinoid system, which plays a role in the normalization of the functions of the immune system. Additionally, CBD may have a direct influence on the gut by interacting with the intestinal microflora, regulating intestinal permeability, modulating immune responses, and affecting the gut-brain axis communication through the vagal signaling pathway. A study was conducted to analyze how different doses of CBD injected intraperitoneal could alter the microbial composition of the duodenum contents in a mouse model. Obtained results suggest that the impact of CBD on the intestine microbiome may be dosage-dependent. Statistical analysis revealed significant differences compared to the control group in the 0.2 mg/kg CBD and 20 mg/kg CBD dose groups for the genera Campilobacteriota, Firmicutes, Proteobacteria, and, specifically in the 0.2 mg CBD group, Cyanobacteria. In contrast, the 10 mg CBD dose group showed no statistically significant differences relative to the control. The Firmicutes phylum had the highest relative abundance in all groups, wherein its share was lower in the CBD-treated groups than in the control group. Lachnospiraceae_NK4A136_group, Muribaculaceae, and Akkermansia were predominant, with Lachnospiraceae_NK4A136_group decreasing and Akkermansia increasing in relative abundance in CBD-treated groups. Of the genera that showed statistically significant differences between groups, most belonged to the phylum Firmicutes, including the dominant Lachnospiraceae_NK4A136_group. These findings suggest that intraperitoneal CBD administration induces alterations in the duodenal microbiome, particularly affecting the Lachnospiraceae_NK4A136_group and the Akkermansia genera. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00294-025-01327-8.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。